Groupe Belge D'Oncologie Digestive

Research activity includes small bowel adenocarcinoma after surgical resection, with interest in adjuvant chemotherapy and postoperative treatment strategies for stage I-IV disease.

• Post-operative fluoropyrimidine therapy
• Oxaliplatin-based combination chemotherapy
• Adjuvant treatment selection

The sponsor is involved in evaluating treatment options that may influence recurrence control and long-term management in resected small bowel adenocarcinoma.